Correlation Between Denali Therapeutics and BridgeBio Pharma
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and BridgeBio Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and BridgeBio Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and BridgeBio Pharma, you can compare the effects of market volatilities on Denali Therapeutics and BridgeBio Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of BridgeBio Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and BridgeBio Pharma.
Diversification Opportunities for Denali Therapeutics and BridgeBio Pharma
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Denali and BridgeBio is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and BridgeBio Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BridgeBio Pharma and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with BridgeBio Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BridgeBio Pharma has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and BridgeBio Pharma go up and down completely randomly.
Pair Corralation between Denali Therapeutics and BridgeBio Pharma
Given the investment horizon of 90 days Denali Therapeutics is expected to under-perform the BridgeBio Pharma. In addition to that, Denali Therapeutics is 1.01 times more volatile than BridgeBio Pharma. It trades about -0.02 of its total potential returns per unit of risk. BridgeBio Pharma is currently generating about -0.01 per unit of volatility. If you would invest 3,070 in BridgeBio Pharma on September 9, 2024 and sell it today you would lose (191.00) from holding BridgeBio Pharma or give up 6.22% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Denali Therapeutics vs. BridgeBio Pharma
Performance |
Timeline |
Denali Therapeutics |
BridgeBio Pharma |
Denali Therapeutics and BridgeBio Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Denali Therapeutics and BridgeBio Pharma
The main advantage of trading using opposite Denali Therapeutics and BridgeBio Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, BridgeBio Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BridgeBio Pharma will offset losses from the drop in BridgeBio Pharma's long position.Denali Therapeutics vs. Stoke Therapeutics | Denali Therapeutics vs. Black Diamond Therapeutics | Denali Therapeutics vs. 4D Molecular Therapeutics | Denali Therapeutics vs. Ascendis Pharma AS |
BridgeBio Pharma vs. Blueprint Medicines Corp | BridgeBio Pharma vs. Amylyx Pharmaceuticals | BridgeBio Pharma vs. Day One Biopharmaceuticals | BridgeBio Pharma vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |